How have FUM shares performed in 2024?

Futura Medical's stock was trading at GBX 25.50 at the start of the year. Since then, FUM shares have increased by 39.2% and is now trading at GBX 35.49. View the best growth stocks for 2024 here .

How were Futura Medical's earnings last quarter?

Futura Medical plc (LON:FUM) issued its quarterly earnings data on Wednesday, September, 16th. The company reported ($0.44) EPS for the quarter. Futura Medical had a negative trailing twelve-month return on equity of 66.35% and a negative net margin of 299.73%.

What other stocks do shareholders of Futura Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV) , Tullow Oil (TLW) , Bigblu Broadband (BBB) , Directa Plus (DCTA) , Genel Energy (GENL) , Lakehouse (LAKE) , Petrel Resources (PET) , People's Operator (TPOP) , CityFibre Infrastructure (CITY) and Paysafe Group (PAYS) .

How do I buy shares of Futura Medical?

Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:FUM

Futura Medical (FUM) Share Price, News & Analysis

→ Here’s how to start a “Weekend Side Hustle” from your sofa (From DTI) (Ad)

Free FUM Stock Alerts

GBX 35.49

-0.01 (-0.03%)

(As of 04:15 PM ET)

Compare

Today's Range: 34.05
▼
36.50
50-Day Range: 35.40
▼
46.25
52-Week Range: 23.28
▼
67

Volume: 473,164 shs
Average Volume: 940,350 shs
Market Capitalization: £106.98 million

P/E Ratio: N/A
Dividend Yield: 4.55%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Get Futura Medical alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Futura Medical Stock (LON:FUM)

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

FUM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FUM Stock News Headlines

April 13, 2024 | americanbankingnews.com

Futura Medical (LON:FUM) Stock Price Crosses Below Two Hundred Day Moving Average of $35.18

April 11, 2024 | finance.yahoo.com

Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

March 14, 2024 | finance.yahoo.com

Futura Medical plc (FUM.L)

March 13, 2024 | finance.yahoo.com

Those who invested in Futura Medical (LON:FUM) five years ago are up 175%

February 6, 2024 | msn.com

Futura Medical shares swell as sales of erectile dysfunction gel boom

January 31, 2024 | lse.co.uk

Futura Medical Share Chat

January 29, 2024 | finance.yahoo.com

With 59% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big guns

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

November 8, 2023 | msn.com

M8 to market Futura’s erectile dysfunction gel in more countries

November 7, 2023 | finance.yahoo.com

Futura Medical continues global expansion with Latin America announcement

November 3, 2023 | finance.yahoo.com

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

October 19, 2023 | proactiveinvestors.com

Futura Medical hails first UAE stockist of ED treatment

October 19, 2023 | proactiveinvestors.com

Futura Medical ED drug roll continues apace

October 5, 2023 | finance.yahoo.com

Futura Medical's (LON:FUM) investors will be pleased with their strong 256% return over the last five years

October 2, 2023 | marketwatch.com

Futura Medical Gets European Patent for Erectile Dysfunction Treatment

October 2, 2023 | proactiveinvestors.com

Futura Medical secures European patent protection for ED gel out to 2040

September 18, 2023 | proactiveinvestors.com.au

Futura Medical targets profitability as erectile dysfunction gel gains commercial traction

September 18, 2023 | proactiveinvestors.com

Futura Medical: Pieces of the jigsaw falling into place, says...

August 22, 2023 | finance.yahoo.com

With 58% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big guns

July 18, 2023 | proactiveinvestors.com

Futura Medical "absolutely delighted" with US commercialisation agreement

June 22, 2023 | proactiveinvestors.com

Futura Medical says early sales of erectile dysfunction gel...Futura Medical says early sales of erectile dysfunction gel met...

June 13, 2023 | markets.businessinsider.com

Futura Granted FDA Approval For OTC Marketing Of MED3000 Gel For Erectile Dysfunction

June 13, 2023 | uk.finance.yahoo.com

FAMDF - Futura Medical plc

June 12, 2023 | finance.yahoo.com

US FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile Dysfunction

June 12, 2023 | proactiveinvestors.com

Futura Medical shares jump 22% in the wake of FDA green light

June 12, 2023 | proactiveinvestors.com

Futura Medical in discussions with US partners after gaining FDA approval

See More Headlines

Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/16/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:FUM
CUSIP: N/A
CIK: N/A
Web: www.futuramedical.com
Phone: +44-1483-685670
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-5,110,000.00
Net Margins: -299.73%
Pretax Margin: N/A
Return on Equity: -66.35%
Return on Assets: -39.40%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.15
Quick Ratio: 5.73

Sales & Book Value

Annual Sales: £1.70 million
Price / Sales: 62.24
Cash Flow: GBX 1.72 per share
Price / Cash Flow: 20.43
Book Value: GBX 3 per share
Price / Book: 11.70

Miscellaneous

Outstanding Shares: 301,450,000
Free Float: N/A
Market Cap: £105.81 million
Optionable: Not Optionable
Beta: 1.26

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. James Henry Barder (Age 65)
CEO & Executive Director
Comp: $397.08k
Ms. Angela Hildreth (Age 44)
COO, Finance Director, Company Secretary & Executive Director
Comp: $310.8k
Mr. Kenneth William James (Age 72)
Head of R&D & Executive Director
Comp: $284.59k
Dr. William Duncan Potter (Age 76)
Chief Scientific Officer & Adviser to the Board
Graham Smith
Head of Alliance Partnerships & Supply
Kevin Langridge
Head of Quality

Key Competitors

View All Competitors

FUM Stock Analysis - Frequently Asked Questions

How have FUM shares performed in 2024?: Futura Medical's stock was trading at GBX 25.50 at the start of the year. Since then, FUM shares have increased by 39.2% and is now trading at GBX 35.49.
View the best growth stocks for 2024 here.
How were Futura Medical's earnings last quarter?: Futura Medical plc (LON:FUM) issued its quarterly earnings data on Wednesday, September, 16th. The company reported ($0.44) EPS for the quarter. Futura Medical had a negative trailing twelve-month return on equity of 66.35% and a negative net margin of 299.73%.
What other stocks do shareholders of Futura Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS).
How do I buy shares of Futura Medical?: Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:FUM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial